SynBioBeta analysis (by Aaron Blotnick) of the USDA conditional license for CPerf LLV, framed around why drugs that persist in the body could change dosing.
Source: SynBioBeta
Back to News
SynBioBeta · October 22, 2026
USDA Greenlights the First Engineered Microbe That Makes Antibodies in the Gut
SynBioBeta analysis (by Aaron Blotnick) of the USDA conditional license for CPerf LLV, framed around why drugs that persist in the body could change dosing.
